Market Overview:
The global bronchodilators market size reached US$
33.8 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$
45.9 Billion by 2027, exhibiting a growth rate (CAGR) of
5.13% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Bronchodilators are medications used to treat patients suffering from long-term conditions of narrow and inflamed airways, such as asthma, emphysema, and chronic obstructive pulmonary disease (COPD). They help relieve associated symptoms by relaxing the muscles around the airways or bronchi, clearing mucus from the lungs, and making breathing easier. They are available in the form of tablets, liquid, nebulizer solutions, and metered-dose and dry powder inhalers. Nowadays, bronchodilators are also utilized to enhance the effect of inhaled corticosteroids, which act as a primary treatment to reduce inflammation and prevent flare-ups in asthma.
Bronchodilators Market Trends:
A significantly rising number of patients with acute respiratory infections due to coronavirus disease (COVID-19) represents one of the key factors influencing the need for bronchodilators across the globe. Apart from this, increasing levels of air pollution, the rising number of smokers, and the growing prevalence of infectious diseases around the world are contributing to the risk of developing lung conditions. This is acting as another growth-inducing factor of the market. In addition, lung function declines gradually with age, which can make breathing slightly difficult. This, along with the increasing geriatric population and a considerable rise in consumer spending capacities, is driving the market. Other factors, such as improving healthcare infrastructure and diagnostic modalities and rising shift towards non-invasive procedures, are also propelling the market growth. Furthermore, several new classes of bronchodilators that can help overcome the limitations of existing products are in the preclinical phase stage. In confluence with this, health agencies of numerous countries are supporting research and development (R&D) activities for bronchodilators, which is anticipated to create a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global bronchodilators market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on indication, drug type and route of administration.
Breakup by Indication:
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Others
Breakup by Drug Type:
- Sympathomimetics
- Anticholinergics
- Phosphodiesterase Inhibitor
- Combination Drugs
Breakup by Route of Administration:
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd. and Vectura Group plc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Indication, Drug Type, Route of Administration, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, AstraZeneca plc, Boehringer Ingelheim International GmbH, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd. and Vectura Group plc |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global bronchodilators market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global bronchodilators market?
- What are the key regional markets?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the route of administration?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global bronchodilators market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Bronchodilators Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Indication
6.1 Asthma
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Chronic Obstructive Pulmonary Disease (COPD)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Others
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Drug Type
7.1 Sympathomimetics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Anticholinergics
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Phosphodiesterase Inhibitor
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Combination Drugs
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Route of Administration
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Injection
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Inhaler
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AstraZeneca plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Boehringer Ingelheim International GmbH
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 F. Hoffmann-La Roche Ltd
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 SWOT Analysis
14.3.5 GlaxoSmithKline plc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 Novartis AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Pfizer Inc.
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Sanofi
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Teva Pharmaceutical Industries Ltd.
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Vectura Group plc
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
List of Figures
Figure 1: Global: Bronchodilators Market: Major Drivers and Challenges
Figure 2: Global: Bronchodilators Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Bronchodilators Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Bronchodilators Market: Breakup by Indication (in %), 2021
Figure 5: Global: Bronchodilators Market: Breakup by Drug Type (in %), 2021
Figure 6: Global: Bronchodilators Market: Breakup by Route of Administration (in %), 2021
Figure 7: Global: Bronchodilators Market: Breakup by Region (in %), 2021
Figure 8: Global: Bronchodilators (Asthma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Bronchodilators (Asthma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Bronchodilators (Chronic Obstructive Pulmonary Disease - COPD) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Bronchodilators (Other Indications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Bronchodilators (Other Indications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Bronchodilators (Sympathomimetics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Bronchodilators (Sympathomimetics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Bronchodilators (Anticholinergics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Bronchodilators (Anticholinergics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Bronchodilators (Phosphodiesterase Inhibitor) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Bronchodilators (Combination Drugs) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Bronchodilators (Combination Drugs) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Bronchodilators (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Bronchodilators (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Bronchodilators (Injection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Bronchodilators (Injection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Bronchodilators (Inhaler) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Bronchodilators (Inhaler) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Bronchodilators Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Bronchodilators Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Bronchodilators Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Bronchodilators Industry: SWOT Analysis
Figure 78: Global: Bronchodilators Industry: Value Chain Analysis
Figure 79: Global: Bronchodilators Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Bronchodilators Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Bronchodilators Market Forecast: Breakup by Indication (in Million US$), 2022-2027
Table 3: Global: Bronchodilators Market Forecast: Breakup by Drug Type (in Million US$), 2022-2027
Table 4: Global: Bronchodilators Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 5: Global: Bronchodilators Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Bronchodilators Market: Competitive Structure
Table 7: Global: Bronchodilators Market: Key Players